Neuroendocrine Carcinoma of the Cervix Overview

Save information for later
Sign Up

Learn About Neuroendocrine Carcinoma of the Cervix

Who are the top Neuroendocrine Carcinoma of the Cervix Local Doctors?
Radiation Oncology
Radiation Oncology

Community Care Services LLC

1155 Mill St, 
Reno, NV 
 (96.8 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Abhinand Peddada is a Radiation Oncologist in Reno, Nevada. Dr. Peddada and is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Gliosarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Peddada is currently accepting new patients.

Gynecologic Oncology | Oncology
Gynecologic Oncology | Oncology

Alameda Health System

1411 E 31st St, 
Oakland, CA 
 (87.9 mi)
Languages Spoken:
English

Dimitry Lerner is a Gynecologic Oncologist and an Oncologist in Oakland, California. Dr. Lerner and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Stromal Sarcoma, Oophorectomy, and Salpingo-Oophorectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (99.2 mi)
Languages Spoken:
English
Offers Telehealth

Amer Karam is a Gynecologic Oncologist and an Oncologist in Stanford, California. Dr. Karam and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His top areas of expertise are Endometrial Cancer, Vulvar Cancer, Ovarian Cancer, Oophorectomy, and Hysterectomy.

What are the latest Neuroendocrine Carcinoma of the Cervix Clinical Trials?
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SNS-101 (Anti VISTA) as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Summary: Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in combination with cemiplimab in patients with advanced solid tumors.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Summary: This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center